#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
The Myelodysplastic Syndrome Specialty Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provides specialized care for children with myelodysplastic syndrome (MDS) and myeloproliferative disease, as well as MDS subtypes such as refractory cytopenia, refractory anemia with excess blasts (RAEB) and RAEB in transformation. We are the only large pediatric center in the country designated as a center of excellence by the MDS Foundation.
Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment and ongoing care of even the rarest and hard-to-treat cancers and blood disorders.
Patients in the Myelodysplastic Syndrome Specialty Program are treated by a team that includes a pediatric hematologist with special expertise in MDS and pathologists with specialized training in pediatric hematopathology. We provide a range of treatment options, including access to one of the nation’s oldest and largest pediatric stem cell transplant programs.
Through our research program and clinical trials, our clinicians and scientists are studying why MDS occurs and developing new treatment options for these conditions. With funding from the National Institutes of Health, we recently established the first nationwide patient registry and tissue repository for pediatric MDS and bone marrow failure disorders.
Learn more about our Myelodysplastic Syndrome Specialty Program on the Dana-Farber/Boston Children’s website.
Pediatric hematologist/oncologist Inga Hofmann, MD, PhD, will host an interactive workshop designed just for kids and teens affected by bone marrow failure at the Aplastic Anemia & MDS International Foundation conference, “Living with Aplastic Anemia, MDS, or PNH,” Sept. 7, 2013, Boston Marriott Peabody. Educational program, art project, face painting, ice cream, and more!
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”